Biochemical effects of KH 1060 and anti-TNF monoclonal antibody on human peripheral blood mononuclear cells

International Immunopharmacology

Volumn 5, Issue 4, 2005, Pages 649-659

  Stio, Maria ^a   Treves, Cristina ^a   Martinesi, Maria ^a   Bonanomi, Andrea G ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Gastroenterology Unit   (Italy)

Author keywords

Anti TNF monoclonal antibody; Oncogenes Bax and Bcl 2; PBMC proliferation; TNF ; Vitamin D analogue KH 1060; Vitamin D receptor

Indexed keywords

CHIMERIC ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEXACALCITOL; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; ONCOPROTEIN; PHYTOHEMAGGLUTININ; PROTEIN BAX; PROTEIN BCL 2; THYMIDINE; TRITIUM; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VITAMIN D DERIVATIVE;

ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INCUBATION TIME; LEUKOCYTE ACTIVATION; MITOSIS INHIBITION; NORMAL HUMAN; ONCOGENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE;

EID: 13844289343     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.11.002     Document Type: Article

References (38)

1. P. Vassalli The pathophysiology of tumor necrosis factors Annu. Rev. Immunol. 10 1992 411 452
2. + T cells Blood 90 1997 1588 1593
3. Z. Liu, H. Hsu, D.V. Goeddel, and M. Karin Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death Cell 87 1996 565 576
4. E. Carballo, W.S. Lai, and P.J. Blackshear Feedback inhibition of macrophage tumor necrosis-α production by tristetrapolin Science 281 1998 1001 1005
5. D.H. Present, P. Rutgeers, S. Targan, S.B. Hanauer, L. Mayer, and R.A. van Hogezand Infliximab for the treatment of fistulas in patients with Crohn's disease N. Engl. J. Med. 340 1999 1398 1405
6. S.R. Targan, S.B. Hanauer, S.J.H. van Deventer, L. Mayer, D.H. Present, T.A.J. Braakman and the Crohn's Disease cA2 Study Group A short-time study of chimeric monoclonal antibody cA2 to tumor necrosis factor for Crohn's disease N. Engl. J. Med. 337 1997 1029 1035
7. A.J. Brawn Regulation of vitamin D action Nephrol. Dial. Transplant. 14 1999 11 16
8. 3 receptor in the immune system Arch. Biochem. Biophys. 374 2000 1659 1664
9. 3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation J. Clin. Endocrinol. Metab. 57 1983 1308 1310
10. R.E. Rocklin, K. Bendtzen, and D. Greineder Mediators of immunity: lymphokines and monokines Adv. Immunol. 29 1980 55 136
11. K.A. Smith, and F.W. Ruscetti T-cell growth factor and the culture of cloned functional T cells Adv. Immunol. 31 1981 137 175
12. 3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes Proc. Natl. Acad. Sci. U. S. A. 84 1987 3385 3389
13. 3: preferential inhibition of Th 1 functions J. Nutr. 125 Suppl. 6 1995 1704S 1708S
14. 3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis Biochem. Pharmacol. 61 2001 365 371
15. M. Stio, C. Treves, A. Celli, O. Tarantino, G. d'Albasio, and A.G. Bonanomi Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis Am. J. Gastroenterol. 97 2002 679 689
16. 3 analogues: a novel class of potent regulators of cell growth and immune responses Biochem. Pharmacol. 42 1991 1569 1575
17. 3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells Cancer Res. 56 1996 3570 3576
18. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
19. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
20. G. Camussi, E. Albano, C. Tetta, and F. Bussolino The molecular action of tumor necrosis factor-alfa Eur. J. Biochem. 202 1991 3 14
21. M.A. O'Connell, R. Cleere, A. Long, L.A.J. O'Neill, and D. Kelleher Cellular proliferation and activation of NFκB are induced by autocrine production of tumor necrosis factor α in the human T lymphoma line HuT 78 J. Biol. Chem. 270 1995 7399 7404
22. L. Manzano, M. Alvarez-Mon, J.A. Vargas, L. Abreu, A. Fenandez-Corugedo, and L.I. Roman Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients Gut 35 1994 955 960
23. C.P. Braegger, S. Nicholls, S.H. Murch, S. Stephens, and T.T. MacDonald Tumor necrosis factor alfa in stool as a marker of intestinal inflammation Lancet 339 1992 89 91
24. J.E. Reittie, K.L. Yong, P. Panayiotidis, and A.V. Hoffbrand Interleukin-6 inhibits apoptosis and tumor necrosis factor induced proliferation of B-chronic lymphocytic leukaemia Leuk. Lymphoma 22 1996 83 90
25. D.G. Alleva, C.J. Burger, and K.D. Elgert Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation Immunobiology 188 1993 430 445
26. V. Vegesna, J. O'Kelly, J. Said, M. Uskokovic, L. Binderup, and H.P. Koeffle Ability of potent vitamin D3 analogs to inhibit growth of prostate cancer cells in vivo Anticancer Res. 23 1A 2003 283 289
27. L. Binderup, S. Latini, E. Binderup, C. Bretting, M. Calverley, and K. Hansen 20-Epi-vitamin D3 analogues: a novel class of potent regulators of cells growth and immune responses Biochem. Pharmacol. 42 8 1991 1569 1575
28. S. de Vos, S. Holden, D. Heber, E. Elstner, L. Binderup, and M. Uskokovic Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines Prostate 31 2 1997 77 83
29. K. Muller, P.M. Haahr, M. Diamant, K. Rieneck, A. Kharazmi, and K. Bendtzen 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level Cytokine 4 1992 506 512
30. 3 Int. J. Immunopharmacol. 13 1991 525 530
31. J.L. Fernandez-Martin, S. Kurian, P. Farmer, and M.S. Nanes Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors Mol. Cell. Endocrinol. 141 1998 65 72
32. N. Mayur, S. Lewis, B.D. Catherwood, and M.S. Nanes Tumor necrosis factor alpha decreases 1,25-dihydroxyvitamin D3 receptors in osteoblastic ROS 17/2.8 cells J. Bone Miner. Res. 8 1993 997 1003
33. A. Gross, J. Jockel, M.C. Wei, and S.J. Korsmeyer Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis EMBO J. 17 1998 3878 3885
34. J.G. Pastorino, S.T. Chen, M. Tafani, J.W. Snyder, and J.L. Farber The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition J. Biol. Chem. 273 1998 7770 7775
35. J.C. Reed Bcl-2 and the regulation of programmed cell death J. Cell Biol. 124 1994 1 6
36. L.H. Boise, M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, and L.A. Turka Bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death Cell 74 1993 597 608
37. Z.N. Oltvai, C.L. Milliman, and S.J. Korsmeyer Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell 74 1993 609 619
38. T. Ten Hove, and S.J.H. van Deventer Anti-TNF antibody Ca2 induces apoptosis in CD3/CD28 stimulated Jurkat cells: A, potent immunomodulatory mechanism Gastroenterology 116 1999 A739